Capital Cell, compañía de inversión especializada en biotech y salud, presenta resultados positivos en el primer trimestre de 2021. Durante este período, la financiera regulada por la CNMW ha leva...
El pasado martes 8 de junio tuvo lugar Facing Challenges Summit Madrid 2021, la primera cumbre europea alrededor del Science Equity (transferencia tecnológica en Deep Science), nueva categoría de in...
Barcelona suma un nuevo fondo para invertir en start-ups . Nina Capital acaba de constituir su segundo vehículo de inversión enfocado a financiar empresas emergentes del sector medtech –medicina y...
TALDE PRIVATE EQUITY and ESPIGA CAPITAL have announced the agreement for the sale of DELTALAB, a European leader in the design, manufacture and distribution of consumables, reagents and laboratory equ...
Moira Capital Partners, firma de inversión en Capital Privado, especializada en inversiones directas en compañías innovadoras españolas, ha entrado en el accionariado de Cella Medical Solutions. C...
The Palex group, leaders in providing advanced solutions in the area of medical supplies, laboratory products and industry materials, with more than 65 years' experience, has expanded its number of sp...
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in eMindful, a leading provider of evidence-based, mindfulness programs for everyday life...
H.I.G. WhiteHorse has committed €110 million in unitranche loans to refinance the borrower’s existing indebtedness and provide additional capital to finance growth, supporting the Company’s expa...
COFIDES is supporting Grupo Ortiz in the design, construction, provision and maintenance of the Bosa Hospital in Colombia. To this end, it will acquire a shareholding percentage of up to 45% of the pr...
COFIDES is backing Profármaco's expansion into the markets of Guatemala, the Dominican Republic and Panama. It will invest two million euros from its own resources, by means of three co-investment lo...
Fundada en Sevilla en 1992 por los doctores Fernando y Pascual Sánchez y con un volumen de negocio superior a 26 millones de euros, Ginemed es uno de los grandes grupos de fertilidad en Iberia, con p...